The integration of lipid-sensing and anti-inflammatory effects: How the PPARs play a role in metabolic balance

Nuclear Receptor

Volumn 5, Issue , 2007, Pages

  Nunn, Alistair V W ^a   Bell, Jimmy ^a   Barter, Philip ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HEART RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXO; UNCOUPLING PROTEIN;

ACUTE PHASE RESPONSE; ADIPOSE TISSUE; CALORIC RESTRICTION; DOWN REGULATION; EMBRYO DEVELOPMENT; ENERGY METABOLISM; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; INJURY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; LIPID STORAGE; LIPID TRANSPORT; METABOLIC BALANCE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PHENOTYPE; PHYSICAL ACTIVITY; PROTEIN FUNCTION; REVIEW; SURVIVAL; WOUND HEALING;

EID: 34447093179     PISSN: None     EISSN: 14781336     Source Type: Journal    
DOI: 10.1186/1478-1336-5-1     Document Type: Review

References (122)

1. Issemann I Green S Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 1990 347 645-650 10.1038/347645a0 2129546
2. Michalik L Desvergne B Dreyer C Gavillet M Laurini RN Wahli W PPAR expression and function during vertebrate development Int J Dev Biol 2002 46 105-114 11902671
3. Froment P Gizard F Defever D Staels B Dupont J Monget P Peroxisome proliferator-activated receptors in reproductive tissues: From gametogenesis to parturition J Endocrinol 2006 189 199-209 10.1677/ joe.1.06667 16648288
4. Kliewer SA Xu HE Lambert MH Willson TM Peroxisome proliferator-activated receptors: From genes to physiology Recent Prog Horm Res 2001 56 239-263 10.1210/rp.56.1.239 11237216
5. Michalik L Wahli W Involvement of PPAR nuclear receptors in tissue injury and wound repair J Clin Invest 2006 116 598-606 1386118 16511592 10.1172/JCI27958
6. Youssef J Badr M Role of Peroxisome Proliferator-Activated Receptors in Inflammation Control J Biomed Biotechnol 2004 2004 156-166 551585 15292582 10.1155/S1110724304308065
7. Lavrovsky Y Chatterjee B Clark RA Roy AK Role of redox-regulated transcription factors in inflammation, aging and age-related diseases Exp Gerontol 2000 35 521-532 10.1016/S0531-5565(00)00118-2 10978675
8. Laudet V Evolution of the nuclear receptor superfamily: Early diversification from an ancestral orphan receptor J Mol Endocrinol 1997 19 207-226 10.1677/jme.0.0190207 9460643
9. Morris BJ A forkhead in the road to longevity: The molecular basis of lifespan becomes clearer J Hypertens 2005 23 1285-1309 15942449
10. Corton JC Brown-Borg HM Peroxisome proliferator-activated receptor gamma coactivator 1 in caloric restriction and other models of longevity J Gerontol A Biol Sci Med Sci 2005 60 1494-1509 16424281
11. Corton JC Apte U Anderson SP Limaye P Yoon L Latendresse J Dunn C Everitt JI Voss KA Swanson C Kimbrough C Wong JS Gill SS Chandraratna RA Kwak MK Kensler TW Stulnig TM Steffensen KR Gustafsson JA Mehendale HM Mimetics of caloric restriction include agonists of lipid-activated nuclear receptors J Biol Chem 2004 279 46204-46212 10.1074/ jbc.M406739200 15302862
12. Russell AP Hesselink MK Lo SK Schrauwen P Regulation of metabolic transcriptional co-activators and transcription factors with acute exercise FASEB J 2005 19 986-988 15814608
13. Metel'skii ST [The relationship of the lifespan of eukaryotes (animals and plants) to their physical characteristics] Zh Obshch Biol 1995 56 723-735 8546014
14. Troen BR The biology of aging Mt Sinai J Med 2003 70 3-2 12516005
15. Escher P Braissant O Basu-Modak S Michalik L Wahli W Desvergne B Rat PPARs: Quantitative analysis in adult rat tissues and regulation in fasting and refeeding Endocrinology 2001 142 4195-4202 10.1210/ en.142.10.4195 11564675
16. Fredenrich A Grimaldi PA PPAR delta: An uncompletely known nuclear receptor Diabetes Metab 2005 31 23-27 10.1016/S1262-3636(07)70162-3 15803109
17. Kim MS Pak YK Jang PG Namkoong C Choi YS Won JC Kim KS Kim SW Kim HS Park JY Kim YB Lee KU Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis Nat Neurosci 2006
18. Puigserver P Wu Z Park CW Graves R Wright M Spiegelman BM A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis Cell 1998 92 829-839 10.1016/S0092-8674(00)81410-5 9529258
19. Puigserver P Spiegelman BM Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): Transcriptional coactivator and metabolic regulator Endocr Rev 2003 24 78-90 10.1210/ er.2002-0012 12588810
20. Puigserver P Rhee J Donovan J Walkey CJ Yoon JC Oriente F Kitamura Y Altomonte J Dong H Accili D Spiegelman BM Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction Nature 2003 423 550-555 10.1038/nature01667 12754525
21. Vega RB Huss JM Kelly DP The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes Mol Cell Biol 2000 20 1868-1876 85369 10669761 10.1128/ MCB.20.5.1868-1876.2000
22. Dowell P Otto TC Adi S Lane MD Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways J Biol Chem 2003 278 45485-45491 10.1074/jbc.M309069200 12966085
23. Kamei Y Mizukami J Miura S Suzuki M Takahashi N Kawada T Taniguchi T Ezaki O A forkhead transcription factor FKHR up-regulates lipoprotein lipase expression in skeletal muscle FEBS Lett 2003 536 232-236 10.1016/ S0014-5793(03)00062-0 12586369
24. Sung B Park S Yu BP Chung HY Modulation of PPAR in aging, inflammation, and calorie restriction J Gerontol A Biol Sci Med Sci 2004 59 997-1006 15528772
25. Spencer NF Poynter ME Im SY Daynes RA Constitutive activation of NF-kappa B in an animal model of aging Int Immunol 1997 9 1581-1588 10.1093/intimm/9.10.1581 9352364
26. Chung HY Sung B Jung KJ Zou Y Yu BP The molecular inflammatory process in aging Antioxid Redox Signal 2006 8 572-581 10.1089/ars.2006.8.572 16677101
27. Poynter ME Daynes RA Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging J Biol Chem 1998 273 32833-32841 10.1074/jbc.273.49.32833 9830030
28. Zhu M Miura J Lu LX Bernier M DeCabo R Lane MA Roth GS Ingram DK Circulating adiponectin levels increase in rats on caloric restriction: the potential for insulin sensitization Exp Gerontol 2004 39 1049-1059 10.1016/j.exger.2004.03.024 15236764
29. Ajuwon KM Spurlock ME Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes Am J Physiol Regul Integr Comp Physiol 2005 288 R1220-R1225 15604306
30. Barish GD Narkar VA Evans RM PPAR delta: A dagger in the heart of the metabolic syndrome J Clin Invest 2006 116 590-597 1386117 16511591 10.1172/JCI27955
31. Finnberg N El-Deiry WS Activating FOXO3a, NF-kappaB and p53 by targeting IKKs: An effective multi-faceted targeting of the tumor-cell phenotype? Cancer Biol Ther 2004 3 614-616 15254408
32. Delerive P De BK Besnard S Vanden BW Peters JM Gonzalez FJ Fruchart JC Tedgui A Haegeman G Staels B Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1 J Biol Chem 1999 274 32048-32054 10.1074/jbc.274.45.32048 10542237
33. Planavila A Laguna JC Vazquez-Carrera M Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy J Biol Chem 2005 280 17464-17471 10.1074/jbc.M414220200 15728586
34. Rival Y Beneteau N Taillandier T Pezet M Dupont-Passelaigue E Patoiseau JF Junquero D Colpaert FC Delhon A PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells Eur J Pharmacol 2002 435 143-151 10.1016/S0014-2999(01)01589-8 11821020
35. Tham DM Martin-McNulty B Wang YX Wilson DW Vergona R Sullivan ME Dole W Rutledge JC Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs Physiol Genomics 2002 11 21-30 12361987
36. Demas GE Sakaria S Leptin regulates energetic tradeoffs between body fat and humoural immunity Proc Biol Sci 2005 272 1845-1850 10.1098/ rspb.2005.3126 16096098
37. Blundell JE Finlayson G Is susceptibility to weight gain characterized by homeostatic or hedonic risk factors for overconsumption? Physiol Behav 2004 82 21-25 10.1016/j.physbeh.2004.04.021 15234585
38. Jebb SA Siervo M Fruhbeck G Goldberg GR Murgatroyd PR Prentice AM Variability of appetite control mechanisms in response to 9 weeks of progressive overfeeding in humans Int J Obes (Lond) 2006 30 1160-1162 10.1038/sj.ijo.0803194 16477273
39. Schwartz MW Woods SC Seeley RJ Barsh GS Baskin DG Leibel RL Is the energy homeostasis system inherently biased toward weight gain? Diabetes 2003 52 232-238 10.2337/diabetes.52.2.232 12540591
40. Cancello R Henegar C Viguerie N Taleb S Poitou C Rouault C Coupaye M Pelloux V Hugol D Bouillot JL Bouloumie A Barbatelli G Cinti S Svensson PA Barsh GS Zucker JD Basdevant A Langin D Clement K Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss Diabetes 2005 54 2277-2286 10.2337/diabetes.54.8.2277 16046292
41. Bodles AM Varma V Yao-Borengasser A Phanavanh B Peterson CA McGehee RE Jr. Rasouli N Wabitsch M Kern PA Pioglitazone induces apoptosis of macrophages in human adipose tissue J Lipid Res 2006 16799131
42. Pitts GCB T.R. Body Composition in Animals and Man. Washington DC, National Academy of Sciences 1968 45-70
43. Luquet S Lopez-Soriano J Holst D Fredenrich A Melki J Rassoulzadegan M Grimaldi PA Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability FASEB J 2003 17 2299-2301 14525942
44. Russell AP Feilchenfeldt J Schreiber S Praz M Crettenand A Gobelet C Meier CA Bell DR Kralli A Giacobino JP Deriaz O Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle Diabetes 2003 52 2874-2881 10.2337/diabetes.52.12.2874 14633846
45. Cosgrove JP Church DF Pryor WA The kinetics of the autoxidation of polyunsaturated fatty acids Lipids 1987 22 299-304 10.1007/BF02533996 3600206
46. Chandel NS Schumacker PT Cellular oxygen sensing by mitochondria: Old questions, new insight J Appl Physiol 2000 88 1880-1889 10.1063/ 1.1303764 10797153
47. Pearlstein DP Ali MH Mungai PT Hynes KL Gewertz BL Schumacker PT Role of mitochondrial oxidant generation in endothelial cell responses to hypoxia Arterioscler Thromb Vasc Biol 2002 22 566-573 10.1161/ 01.ATV.0000012262.76205.6A 11950692
48. Cramer T Johnson RS A novel role for the hypoxia inducible transcription factor HIF-1alpha: Critical regulation of inflammatory cell function Cell Cycle 2003 2 192-193 12734422
49. Narravula S Colgan SP Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia J Immunol 2001 166 7543-7548 11390509
50. Yun Z Maecker HL Johnson RS Giaccia AJ Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: A mechanism for regulation of adipogenesis by hypoxia Dev Cell 2002 2 331-341 10.1016/ S1534-5807(02)00131-4 11879638
51. Figueroa YG Chan AK Ibrahim R Tang Y Burow ME Alam J Scandurro AB Beckman BS NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression Exp Hematol 2002 30 1419-1427 10.1016/S0301-472X(02)00934-7 12482504
52. Jung YJ Isaacs JS Lee S Trepel J Neckers L IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis FASEB J 2003 17 2115-2117 12958148
53. Sugden MC Bulmer K Gibbons GF Holness MJ Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding Arch Biochem Biophys 2001 395 246-252 10.1006/abbi.2001.2586 11697863
54. Aubert J Champigny O Saint-Marc P Negrel R Collins S Ricquier D Ailhaud G Up-regulation of UCP-2 gene expression by PPAR agonists in preadipose and adipose cells Biochem Biophys Res Commun 1997 238 606P-611 10.1006/ bbrc.1997.7348 9299560
55. Kelly LJ Vicario PP Thompson GM Candelore MR Doebber TW Ventre J Wu MS Meurer R Forrest MJ Conner MW Cascieri MA Moller DE Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression Endocrinology 1998 139 4920-4927 10.1210/en.139.12.4920 9832429
56. Sears IB MacGinnitie MA Kovacs LG Graves RA Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: Regulation by peroxisome proliferator-activated receptor gamma Mol Cell Biol 1996 16 3410-3419 231335 8668156
57. Thompson MP Kim D Links between fatty acids and expression of UCP2 and UCP3 mRNAs FEBS Lett 2004 568 4-9 10.1016/j.febslet.2004.05.011 15196910
58. Jezek P Zackova M Ruzicka M Skobisova E Jaburek M Mitochondrial uncoupling proteins--facts and fantasies Physiol Res 2004 53 Suppl 1 S199-S211 15119950
59. Sullivan PG Rippy NA Dorenbos K Concepcion RC Agarwal AK Rho JM The ketogenic diet increases mitochondrial uncoupling protein levels and activity Ann Neurol 2004 55 576-580 10.1002/ana.20062 15048898
60. Xiao H Massaro D Massaro GD Clerch LB Expression of lung uncoupling protein-2 mRNA is modulated developmentally and by caloric intake Exp Biol Med (Maywood) 2004 229 479-485 15169966
61. Carroll AM Porter RK Starvation-sensitive UCP 3 protein expression in thymus and spleen mitochondria Biochim Biophys Acta 2004 1700 145-150 15262223
62. Armstrong MB Towle HC Polyunsaturated fatty acids stimulate hepatic UCP-2 expression via a PPARalpha-mediated pathway Am J Physiol Endocrinol Metab 2001 281 E1197-E1204 11701434
63. Reilly JM Thompson MP Dietary fatty acids Up-regulate the expression of UCP2 in 3T3-L1 preadipocytes Biochem Biophys Res Commun 2000 277 541-545 10.1006/bbrc.2000.3705 11061990
64. Zackova M Skobisova E Urbankova E Jezek P Activating omega-6 polyunsaturated fatty acids and inhibitory purine nucleotides are high affinity ligands for novel mitochondrial uncoupling proteins UCP2 and UCP3 J Biol Chem 2003 278 20761-20769 10.1074/jbc.M212850200 12670931
65. Ledesma A de Lacoba MG Rial E The mitochondrial uncoupling proteins Genome Biol 2002 3 REVIEWS3015 151194 12537581 10.1186/ gb-2002-3-12-reviews3015
66. Schrauwen P Mensink M Schaart G Moonen-Kornips E Sels JP Blaak EE Russell AP Hesselink MK Reduced skeletal muscle uncoupling protein-3 content in prediabetic subjects and type 2 diabetic patients: restoration by rosiglitazone treatment J Clin Endocrinol Metab 2006 91 1520-1525 10.1210/jc.2005-1572 16384852
67. Becuwe P Bianchi A Keller JM Dauca M Effects of the peroxisome proliferator clofibric acid on superoxide dismutase expression in the human HepG2 hepatoma cell line Biochem Pharmacol 1999 58 1025-1033 10.1016/S0006-2952(99)00174-4 10509755
68. Inoue I Goto S Matsunaga T Nakajima T Awata T Hokari S Komoda T Katayama S The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells Metabolism 2001 50 3-11 10.1053/meta.2001.19415 11172467
69. Yoo HY Chang MS Rho HM Induction of the rat Cu/Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid Gene 1999 234 87-91 10.1016/S0378-1119(99)00176-6 10393242
70. Lee CH Olson P Hevener A Mehl I Chong LW Olefsky JM Gonzalez FJ Ham J Kang H Peters JM Evans RM PPARdelta regulates glucose metabolism and insulin sensitivity Proc Natl Acad Sci U S A 2006 103 3444-3449 1413918 16492734 10.1073/pnas.0511253103
71. Haluzik MM Lacinova Z Dolinkova M Haluzikova D Housa D Horinek A Vernerova Z Kumstyrova T Haluzik M Improvement of Insulin Sensitivity after Peroxisome Proliferator-Activated Receptor-{alpha} Agonist Treatment Is Accompanied by Paradoxical Increase of Circulating Resistin Levels Endocrinology 2006 147 4517-4524 10.1210/en.2005-1624 16740970
72. Ye JM Doyle PJ Iglesias MA Watson DG Cooney GJ Kraegen EW Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: Comparison with PPAR-gamma activation Diabetes 2001 50 411-417 10.2337/ diabetes.50.2.411 11272155
73. Boden G Lebed B Schatz M Homko C Lemieux S Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects Diabetes 2001 50 1612-1617 10.2337/ diabetes.50.7.1612 11423483
74. Houstis N Rosen ED Lander ES Reactive oxygen species have a causal role in multiple forms of insulin resistance Nature 2006 440 944-948 10.1038/ nature04634 16612386
75. Tripathy D Mohanty P Dhindsa S Syed T Ghanim H Aljada A Dandona P Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects Diabetes 2003 52 2882-2887 10.2337/ diabetes.52.12.2882 14633847
76. Boden G She P Mozzoli M Cheung P Gumireddy K Reddy P Xiang X Luo Z Ruderman N Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver Diabetes 2005 54 3458-3465 10.2337/diabetes.54.12.3458 16306362
77. Goldstein BJ Mahadev K Wu X Zhu L Motoshima H Role of insulin-induced reactive oxygen species in the insulin signaling pathway Antioxid Redox Signal 2005 7 1021-1031 1434604 15998257 10.1089/ars.2005.7.1021
78. NEEL JV Diabetes mellitus: A "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 1962 14 353-362 13937884
79. Ruiz-Narvaez E Is the Ala12 variant of the PPARG gene an "unthrifty allele"? J Med Genet 2005 42 547-550 10.1136/jmg.2004.026765 15994875
80. Stannard SR Johnson NA Insulin resistance and elevated triglyceride in muscle: More important for survival than "thrifty" genes? J Physiol 2004 554 595-607 1664785 14608009 10.1113/jphysiol.2003.053926
81. Cettour-Rose P Samec S Russell AP Summermatter S Mainieri D Carrillo-Theander C Montani JP Seydoux J Rohner-Jeanrenaud F Dulloo AG Redistribution of glucose from skeletal muscle to adipose tissue during catch-up fat: A link between catch-up growth and later metabolic syndrome Diabetes 2005 54 751-756 10.2337/diabetes.54.3.751 15734852
82. Yamamoto M Clark JD Pastor JV Gurnani P Nandi A Kurosu H Miyoshi M Ogawa Y Castrillon DH Rosenblatt KP M K Regulation of oxidative stress by the anti-aging hormone klotho J Biol Chem 2005 280 38029-38034 10.1074/ jbc.M509039200 16186101
83. Tsintzas K Jewell K Kamran M Laithwaite D Boonsong T Littlewood J Macdonald I Bennett A Differential regulation of metabolic genes in skeletal muscle during starvation and refeeding in humans J Physiol 2006 575 291-303 10.1113/jphysiol.2006.109892 16763003
84. Johnson NA Stannard SR Rowlands DS Chapman PG Thompson CH O'Connor H Sachinwalla T Thompson MW Effect of short-term starvation versus high-fat diet on intramyocellular triglyceride accumulation and insulin resistance in physically fit men Exp Physiol 2006 91 693-703 10.1113/ expphysiol.2006.033399 16627573
85. Duska F Andel M Kubena A Macdonald IA Effects of acute starvation on insulin resistance in obese patients with and without type 2 diabetes mellitus Clin Nutr 2005 24 1056-1064 10.1016/j.clnu.2005.08.008 16185788
86. Koffler M Kisch ES Starvation diet and very-low-calorie diets may induce insulin resistance and overt diabetes mellitus J Diabetes Complications 1996 10 109-112 10.1016/1056-8727(94)00077-8 8777329
87. Gremlich S Nolan C Roduit R Burcelin R Peyot ML ghingaro-Augusto V Desvergne B Michalik L Prentki M Wahli W Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor alpha transcriptional up-regulation of fatty acid oxidation Endocrinology 2005 146 375-382 10.1210/en.2004-0667 15459119
88. Ito E Ozawa S Takahashi K Tanaka T Katsuta H Yamaguchi S Maruyama M Takizawa M Katahira H Yoshimoto K Nagamatsu S Ishida H PPAR-gamma overexpression selectively suppresses insulin secretory capacity in isolated pancreatic islets through induction of UCP-2 protein Biochem Biophys Res Commun 2004 324 810-814 10.1016/j.bbrc.2004.08.238 15474499
89. Stein DT Stevenson BE Chester MW Basit M Daniels MB Turley SD McGarry JD The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation J Clin Invest 1997 100 398-403 508203 9218517
90. Hirasawa A Tsumaya K Awaji T Katsuma S Adachi T Yamada M Sugimoto Y Miyazaki S Tsujimoto G Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 Nat Med 2005 11 90-94 10.1038/nm1168 15619630
91. Riserus U Tan GD Fielding BA Neville MJ Currie J Savage DB Chatterjee VK Frayn KN O'Rahilly S Karpe F Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: Link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma Diabetes 2005 54 1379-1384 10.2337/ diabetes.54.5.1379 15855323
92. Berg AH Lin Y Lisanti MP Scherer PE Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity Am J Physiol Endocrinol Metab 2004 287 E1178-E1188 10.1152/ajpendo.00002.2004 15251865
93. Fernandez-Real JM Ricart W Insulin resistance and inflammation in an evolutionary perspective: The contribution of cytokine genotype/ phenotype to thriftiness Diabetologia 1999 42 1367-1374 10.1007/ s001250051451 10550422 10550422
94. Goldstein SA Elwyn DH The effects of injury and sepsis on fuel utilization Annu Rev Nutr 1989 9 445-473 10.1146/ annurev.nu.09.070189.002305 2669881
95. Mizock BA Alterations in carbohydrate metabolism during stress: A review of the literature Am J Med 1995 98 75-84 10.1016/S0002-9343(99)80083-7 7825623
96. Bessey PQ Lowe KA Early hormonal changes affect the catabolic response to trauma Ann Surg 1993 218 476-489 1243003 8215639 10.1097/ 00000658-199310000-00008
97. Wisse BE Schwartz MW Cummings DE Melanocortin signaling and anorexia in chronic disease states Ann N Y Acad Sci 2003 994 275-281 12851326
98. Sachot C Poole S Luheshi GN Circulating leptin mediates lipopolysaccharide-induced anorexia and fever in rats J Physiol 2004 561 263-272 1665347 15388782 10.1113/jphysiol.2004.074351
99. Sahu A Metlakunta AS Hypothalamic phosphatidylinositol 3-kinase-phosphodiesterase 3B-cyclic AMP pathway of leptin signalling is impaired following chronic central leptin infusion J Neuroendocrinol 2005 17 720-726 10.1111/j.1365-2826.2005.01362.x 16219000
100. De Souza CT Araujo EP Bordin S Ashimine R Zollner RL Boschero AC Saad MJ Velloso LA Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus Endocrinology 2005 146 4192-4199 10.1210/en.2004-1520 16002529
101. Pickup JC Mattock MB Chusney GD Burt D NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X Diabetologia 1997 40 1286-1292 10.1007/ s001250050822 9389420
102. Duncan BB Schmidt MI Chronic activation of the innate immune system may underlie the metabolic syndrome Sao Paulo Med J 2001 119 122-127 10.1590/ S1516-31802001000300008 11391456
103. Campos SP Baumann H Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes Mol Cell Biol 1992 12 1789-1797 369622 1372389
104. Fernandez-Real JM Vayreda M Richart C Gutierrez C Broch M Vendrell J Ricart W Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women J Clin Endocrinol Metab 2001 86 1154-1159 10.1210/jc.86.3.1154 11238501
105. Vozarova B Fernandez-Real JM Knowler WC Gallart L Hanson RL Gruber JD Ricart W Vendrell J Richart C Tataranni PA Wolford JK The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians Hum Genet 2003 112 409-413 12589429
106. Lu B Moser AH Shigenaga JK Feingold KR Grunfeld C Repression of type II nuclear hormone receptors, receptor coactivators, and their target genes in adipose tissues during the acute-phase response J Lipid Res 2006
107. Stienstra R Lichtenauer-Kaligis E Muller M Stress- (and diet-) related regulation of hepatic nuclear receptors and its relevance for ABC-transporter functions Drug Metab Rev 2004 36 391-406 10.1081/ DMR-120037573 15237861
108. Jamaluddin M Meng T Sun J Boldogh I Han Y Brasier AR Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: A stimulus-specific pathway for NF-kappaB activation Mol Endocrinol 2000 14 99-113 10.1210/me.14.1.99 10628750
109. Phillips MI Kagiyama S Angiotensin II as a pro-inflammatory mediator Curr Opin Investig Drugs 2002 3 569-577 12090726
110. Chen YC Shen SC Tsai SH Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species Biochim Biophys Acta 2005 1743 291-304 10.1016/j.bbamcr.2004.10.016 15843042
111. Pandhare J Cooper SK Phang JM Proline oxidase, a proapoptotic gene, is induced by troglitazone: Evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms J Biol Chem 2006 281 2044-2052 10.1074/jbc.M507867200 16303758
112. Pignatelli M Sanchez-Rodriguez J Santos A Perez-Castillo A 15-deoxy-Delta-12,14-prostaglandin J2 induces programmed cell death of breast cancer cells by a pleiotropic mechanism Carcinogenesis 2005 26 81-92 10.1093/carcin/bgh308 15485993
113. Balkwill F Mantovani A Inflammation and cancer: Back to Virchow? Lancet 2001 357 539-545 10.1016/S0140-6736(00)04046-0 11229684
114. Kitamura T Feng Y Kitamura YI Chua SC Jr. Xu AW Barsh GS Rossetti L Accili D Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake Nat Med 2006 12 534-540 10.1038/nm1392 16604086
115. Eaton SB Konner M Shostak M Stone agers in the fast lane: Chronic degenerative diseases in evolutionary perspective Am J Med 1988 84 739-749 10.1016/0002-9343(88)90113-1 3135745
116. Hu FB Plant-based foods and prevention of cardiovascular disease: An overview Am J Clin Nutr 2003 78 544S-551S 12936948
117. Mendis S Samarajeewa U Thattil RO Coconut fat and serum lipoproteins: effects of partial replacement with unsaturated fats Br J Nutr 2001 85 583-589 11348573
118. Simon JA Hodgkins ML Browner WS Neuhaus JM Bernert JT Jr. Hulley SB Serum fatty acids and the risk of coronary heart disease Am J Epidemiol 1995 142 469-476 7677125
119. Lindstrom J Louheranta A Mannelin M Rastas M Salminen V Eriksson J Uusitupa M Tuomilehto J The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity Diabetes Care 2003 26 3230-3236 10.2337/diacare.26.12.3230 14633807
120. Diamant M Heine RJ Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence Drugs 2003 63 1373-1405 10.2165/ 00003495-200363130-00004 12825962
121. Elisaf M Effects of fibrates on serum metabolic parameters Curr Med Res Opin 2002 18 269-276 10.1185/030079902125000516 12240789
122. Nissen SE Wolski K Topol EJ Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus JAMA 2005 294 2581-2586 10.1001/jama.294.20.joc50147 16239637